We work onFibrobodies®: Pan-fibrosis drug delivery vectors

Fibrobodies®: Pan-fibrosis drug delivery vectors

The impact of Fibrobodies®

Small, smart, and selective

Cost-effective, simple design

Suitable for diagnosis and treatment

Selective for activated myofibroblasts

Pipeline

Development of Fibrobodies® and Fibrobody®-Drug Conjugates
Candidate Disease Discovery Preclinical Clinical phase I/II Clinical phase II/III

We work with

The team at LinXis

Pioneering in the field of Fibrobody-Drug Conjugates

Our multidisciplinary team comprises chemists, biologists, biotechnicians and drug development specialists 

Read more
Reach out

LinXis is always open to partner up with your company

Become a partner